Queensland Brain Institute Annual Report 2019 Vice-Chancellor’S Message

Total Page:16

File Type:pdf, Size:1020Kb

Queensland Brain Institute Annual Report 2019 Vice-Chancellor’S Message Queensland Brain Institute Annual Report 2019 Vice-Chancellor’s message Front cover: Astrocytes, the most common neural cell type, grown on a dish. These cells were used to study glioblastoma, the most common malignant brain cancer in adults. By Zorana Lynton, Richards group, People's Choice Winner, 2019 Art in Neuroscience competition. Above: Jacaranda blooms in UQ's Great Court. The Queensland Brain Institute (QBI) is a world-leading neuroscience research institute, located on our St Lucia campus. It is dedicated to unravelling the secrets of our brain, an immensely complex structure at the core of every activity we undertake as humans. QBI research has the potential to not only within the Medical Research Future translational research, it is important to unlock fundamental knowledge about who Fund to create a business case for the acknowledge that translation requires a we are and how our brain works, but also establishment of a new industry sector in foundation of knowledge from which to to stem the growing tide of brain diseases therapeutic ultrasound. The work is being draw. In recognition of the importance of that have such a devastating social and done in collaboration with partners from discovery research aimed at generating economic impact on our world. across Australia and New Zealand and was new knowledge, and to provide funding the only project in Queensland to receive certainty, QBI has established a Discovery 2019 saw some important steps forward in Research Endowment Fund. this mission. Stage One funding from the MRFF Frontier Health and Medical Research scheme. This fund, which will be officially One of the most exciting projects at launched in 2020, is an ambitious, QBI research has also provided the basis QBI, and one which elicits great interest long-term undertaking that recognises for a trial into the effect of exercise on from around the world, is the ultrasound the importance of pursuing avenues of technology from the laboratory of cognitive function in ageing adults. enquiry without immediate gain. The Professor Jürgen Götz, Director of QBI’s The trial aims to establish the level vision is to provide QBI researchers with Clem Jones Centre for Ageing Dementia and intensity of exercise that improves the intellectual freedom to investigate the Research. Professor Götz and his team are cognitive function, and also to investigate brain and tackle projects where the benefit working on an ultrasound device that could the underlying mechanisms that enable may not be immediately apparent during more effectively deliver therapeutics to exercise to positively affect the brain. This the course of the standard grant cycle. the brain for the treatment of Alzheimer’s research, which is generously supported QBI is one of the forces behind UQ’s disease. The team has spent the past 12 by the Stafford Fox Foundation, has been continued position in the world’s top months working towards a first-in-human proceeding in partnership with UQ's 100 universities, providing high-quality trial of their device. School of Human Movement and Nutrition neuroscience research, driven through local Science. It is hoped that a full analysis of In addition to the potential for this and global collaborations with researchers, the data gathered will be available in 2020. technology to improve our healthcare industry, government and philanthropists. We are grateful to all of the members of and quality of life, the development our community who helped drive this Congratulations to Professor Sah and the of an effective device to treat brain research by participating in the trial. QBI team on their commitment and their diseases would also seed opportunities excellent results. I look forward to watching in the medical device industry and create The trials outlined above are excellent QBI continue to create positive change in jobs within manufacturing and with illustrations of projects that began through the years to come. service providers. In recognition of this curiosity-driven, fundamental research, technology’s potential, the Australian and are now being translated to improve Professor Peter Høj AC Government awarded $1 million in funding lives through better health. As competitive Vice-Chancellor and President from a fiercely competitive scheme funding continues to emphasise The University of Queensland QUEENSLAND BRAIN INSTITUTE ANNUAL REPORT 2019 1 Chairman’s Message 2019 has been an outstanding year for Professor Annemaree Carroll for taking the Foundation, whose continued generous QBI, with significant accomplishments time to provide us with an insight into their support has helped QBI to continue its across many areas. very interesting and ever-evolving work. important work. The past year was marked by the Thanks also to Professor Pankaj Sah for his QBI’s success in its field is a testament to introduction of QBI’s Discovery Research continued leadership of the Institute and the efforts of the entire team of scientists Endowment Fund which will focus on the reappointment as Director for the next five and support staff, whose passion and future sustainability of QBI. The greatest years. His guidance through this year’s UQ tireless commitment to the science that barrier to QBI’s future success is financial: 7-Year Review process also resulted in very underpins our success, helps ensure that without sustainable funding, the Institute positive results for the Institute, which is an we continue to be a world leader in the will find it increasingly difficult to retain outstanding achievement. area of neuroscience research. The progress high, performing staff and support critical of QBI’s dementia research, is just one Some highlights of the year included: research areas. The Endowment Fund has example of how QBI is leading the way been established and will continue to build • The establishment of the Human Brain through cutting-edge research. Professor over the coming years helping to support Studies Unit which will facilitate more Jürgen Götz and his team within QBI’s all scientists in the Institute who are efficient translation of science to clinical Clem Jones Centre for Ageing Dementia concentrating on curiosity-driven research practice, and provide QBI with an Research are currently working towards in the hope of making the next big scientific accessible public face through its human the first stage of a clinical safety trial for discovery. research activities. their non-invasive ultrasound technology • Successful fundraising events including in tackling Alzheimer’s disease, while In yet another busy year for the Institute, the Hand Heart Pocket Alzheimer’s Emeritus Professor Perry Bartlett, Founding I would like to extend a personal thank Gala and the Ross Maclean Race Day, Director of QBI, is leading the development you to my fellow board members for their which helped contribute to continued of a clinical trial for a potential treatment commitment and ongoing support of QBI. philanthropic growth. for motor neurone disease. The advice and guidance provided from the Board’s perspective has helped raise • A high level of grant success. The urgent need to find strategies to awareness of the work of QBI to a broader I am also grateful to all at QBI: our prevent, diagnose and treat dementia, and audience. A special thank you also goes researchers, and our support and technical many other brain-related diseases, is the to Provost, Professor Aidan Byrne and staff, for their passion and tireless focus of QBI’s researchers who are working Pro-Vice Chancellor, Professor Tim Dunne, commitment to the science that underpins hard towards achieving this goal. Based for their attendance at our Board meetings, our success, plus the Advancement team on our history of achievement and current which helps provide a better understanding for their wonderful support to QBI in all initiatives at QBI, and with strong ongoing of how the University functions and QBI’s areas. support from UQ and our external partners role in this process. and donors, we will capitalise on our many The Board would like to express its deep successes and face challenges as they arise. The addition of one of QBI’s researchers gratitude to the Government, foundations, I am looking forward to supporting QBI in presenting at each meeting has enabled corporates, industry partners and countless the exciting times ahead. the Board to gain a greater understanding individuals for generously supporting of the many and varied research activities QBI’s work over the past year. I would which take place at the Institute. I would like to especially mention the Clem Jones Jeff Maclean like to thank Professor Linda Richards, Foundation, Brazil Family Foundation Chairman Dr Steven Zuryn, Dr Susannah Tye and and the Stafford Fox Medical Research QBI Advisory Board 2 QUEENSLAND BRAIN INSTITUTE ANNUAL REPORT 2019 Director’s Message Looking back on 2019, I’m proud to say in Australia, keeping up the momentum to We also built on our existing global we’ve gone from strength to strength, continue our life-changing work advancing partnerships, with exciting advances in our continuing to grow our reputation as treatments for Alzheimer’s disease and collaboration with the Southern University an institution of excellent neuroscience brain diseases more generally. of Science and Technology (SUSTech) in research that is delivering real impact in Shenzhen, China. Together with researchers Our grant success was complemented by understanding the brain. from UQ’s Faculty of Engineering, philanthropic funding from our generous Architecture and IT, we progressed a joint There’s no doubt that this is the result of the donors. This supports research that may SUSTech-UQ neural bioengineering Masters outstanding accomplishments made across not be funded through other national program, where students will be able to so many areas of QBI by the talented schemes, and accelerates discoveries for complete three years of an undergraduate researchers, teams and partnerships the benefit of the community.
Recommended publications
  • ANNUAL REVIEW 1 October 2005–30 September
    WELLCOME TRUST ANNUAL REVIEW 1 October 2005–30 September 2006 ANNUAL REVIEW 2006 The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. It funds innovative biomedical research, in the UK and internationally, spending around £500 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research and its impact on health and wellbeing. www.wellcome.ac.uk THE WELLCOME TRUST The Wellcome Trust is the largest charity in the UK and the second largest medical research charity in the world. 123 CONTENTS BOARD OF GOVERNORS 2 Director’s statement William Castell 4 Advancing knowledge Chairman 16 Using knowledge Martin Bobrow Deputy Chairman 24 Engaging society Adrian Bird 30 Developing people Leszek Borysiewicz 36 Facilitating research Patricia Hodgson 40 Developing our organisation Richard Hynes 41 Wellcome Trust 2005/06 Ronald Plasterk 42 Financial summary 2005/06 Alastair Ross Goobey 44 Funding developments 2005/06 Peter Smith 46 Streams funding 2005/06 Jean Thomas 48 Technology Transfer Edward Walker-Arnott 49 Wellcome Trust Genome Campus As at January 2007 50 Public Engagement 51 Library and information resources 52 Advisory committees Images 1 Surface of the gut. 3 Zebrafish. 5 Cells in a developing This Annual Review covers the 2 Young children in 4 A scene from Y fruit fly. Wellcome Trust’s financial year, from Kenya. Touring’s Every Breath. 6 Data management at the Sanger Institute. 1 October 2005 to 30 September 2006. CONTENTS 1 45 6 EXECUTIVE BOARD MAKING A DIFFERENCE Developing people: To foster a Mark Walport The Wellcome Trust’s mission is research community and individual Director to foster and promote research with researchers who can contribute to the advancement and use of knowledge Ted Bianco the aim of improving human and Director of Technology Transfer animal health.
    [Show full text]
  • EMBO Facts & Figures
    excellence in life sciences Reykjavik Helsinki Oslo Stockholm Tallinn EMBO facts & figures & EMBO facts Copenhagen Dublin Amsterdam Berlin Warsaw London Brussels Prague Luxembourg Paris Vienna Bratislava Budapest Bern Ljubljana Zagreb Rome Madrid Ankara Lisbon Athens Jerusalem EMBO facts & figures HIGHLIGHTS CONTACT EMBO & EMBC EMBO Long-Term Fellowships Five Advanced Fellows are selected (page ). Long-Term and Short-Term Fellowships are awarded. The Fellows’ EMBO Young Investigators Meeting is held in Heidelberg in June . EMBO Installation Grants New EMBO Members & EMBO elects new members (page ), selects Young EMBO Women in Science Young Investigators Investigators (page ) and eight Installation Grantees Gerlind Wallon EMBO Scientific Publications (page ). Programme Manager Bernd Pulverer S Maria Leptin Deputy Director Head A EMBO Science Policy Issues report on quotas in academia to assure gender balance. R EMBO Director + + A Conducts workshops on emerging biotechnologies and on H T cognitive genomics. Gives invited talks at US National Academy E IC of Sciences, International Summit on Human Genome Editing, I H 5 D MAN 201 O N Washington, DC.; World Congress on Research Integrity, Rio de A M Janeiro; International Scienti c Advisory Board for the Centre for Eilish Craddock IT 2 015 Mammalian Synthetic Biology, Edinburgh. Personal Assistant to EMBO Fellowships EMBO Scientific Publications EMBO Gold Medal Sarah Teichmann and Ido Amit receive the EMBO Gold the EMBO Director David del Álamo Thomas Lemberger Medal (page ). + Programme Manager Deputy Head EMBO Global Activities India and Singapore sign agreements to become EMBC Associate + + Member States. EMBO Courses & Workshops More than , participants from countries attend 6th scienti c events (page ); participants attend EMBO Laboratory Management Courses (page ); rst online course EMBO Courses & Workshops recorded in collaboration with iBiology.
    [Show full text]
  • Externally Induced Frontoparietal Synchronization Modulates Network Dynamics and Enhances Working Memory Performance
    RESEARCH ARTICLE Externally induced frontoparietal synchronization modulates network dynamics and enhances working memory performance Ines R Violante1,2*, Lucia M Li1, David W Carmichael3, Romy Lorenz1, Robert Leech1, Adam Hampshire1, John C Rothwell2, David J Sharp1 1The Computational, Cognitive and Clinical Neuroimaging Laboratory, Department of Medicine, Imperial College London, London, United Kingdom; 2Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, University College London, London, United Kingdom; 3Developmental Imaging and Biophysics Section, UCL Institute of Child Health, University College London, London, United Kingdom Abstract Cognitive functions such as working memory (WM) are emergent properties of large- scale network interactions. Synchronisation of oscillatory activity might contribute to WM by enabling the coordination of long-range processes. However, causal evidence for the way oscillatory activity shapes network dynamics and behavior in humans is limited. Here we applied transcranial alternating current stimulation (tACS) to exogenously modulate oscillatory activity in a right frontoparietal network that supports WM. Externally induced synchronization improved performance when cognitive demands were high. Simultaneously collected fMRI data reveals tACS effects dependent on the relative phase of the stimulation and the internal cognitive processing state. Specifically, synchronous tACS during the verbal WM task increased parietal activity, which correlated with behavioral performance. Furthermore, functional connectivity results indicate that *For correspondence: i.violante@ the relative phase of frontoparietal stimulation influences information flow within the WM network. imperial.ac.uk Overall, our findings demonstrate a link between behavioral performance in a demanding WM task Competing interests: The and large-scale brain synchronization. authors declare that no DOI: 10.7554/eLife.22001.001 competing interests exist.
    [Show full text]
  • A N N U a L R E P O R T 2 0
    0 1 0 2 Acknowledgements T R HFSPO is grateful for the support of the following organizations: O P Australia E R National Health and Medical Research Council (NHMRC) L Canada A Canadian Institute of Health Research (CIHR) U Natural Sciences and Engineering Research Council (NSERC) N European Union N European Commission - A Directorate General Information Society (DG INFSO) European Commission - Directorate General Research (DG RESEARCH) France Communauté Urbaine de Strasbourg (CUS) Ministère des Affaires Etrangères et Européennes (MAEE) Ministère de l’Enseignement Supérieur et de la Recherche (MESR) Région Alsace Germany Federal Ministry of Education and Research (BMBF) India Department of Biotechnology (DBT), Ministry of Science and Technology Italy Ministry of Education, University and Research (CNR) Japan Ministry for Economy, Trade and Industry (METI) Ministry of Education, Culture, Sports, Science and Technology (MEXT) Republic of Korea Ministry of Education, Science and Technology (MEST) New Zealand Health Research Council (HRC) Norway Research Council of Norway (RCN) Switzerland State Secretariat for Education and Research (SER) United Kingdom The International Human Frontier Science Biotechnology and Biological Sciences Research Program Organization (HFSPO) Council (BBSRC) 12 quai Saint Jean - BP 10034 Medical Research Council (MRC) 67080 Strasbourg CEDEX - France Fax. +33 (0)3 88 32 88 97 United States of America e-mail: [email protected] National Institutes of Health (NIH) Web site: www.hfsp.org National Science Foundation (NSF) Japanese web site: http://jhfsp.jsf.or.jp HUMAN FRONTIER SCIENCE PROGRAM The Human Frontier Science Program is unique, supporting international collaboration to undertake innovative, risky, basic research at the frontiers of the life sciences.
    [Show full text]
  • Dynamic Interplay Between H-Current and M-Current Controls Motoneuron Hyperexcitability in Amyotrophic Lateral Sclerosis
    University of Wollongong Masthead Logo Research Online Illawarra Health and Medical Research Institute Faculty of Science, Medicine and Health 2019 Dynamic interplay between H-current and M- current controls motoneuron hyperexcitability in amyotrophic lateral sclerosis Yossi Buskila Western Sydney University Orsolya S. Kekesi Western Sydney University, University of Wollongong, [email protected] Alba Bellot-Saez Western Sydney University Wei Lin Seah Western Sydney University, University of Wollongong, [email protected] Tracey Berg University of Wollongong, [email protected] See next page for additional authors Publication Details Buskila, Y., Kekesi, O., Bellot-Saez, A., Seah, W., Berg, T., Trpceski, M., Yerbury, J. J. & Ooi, L. (2019). Dynamic interplay between H- current and M-current controls motoneuron hyperexcitability in amyotrophic lateral sclerosis. Cell Death and Disease, 10 (4), 310-1-310-13. Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library: [email protected] Dynamic interplay between H-current and M-current controls motoneuron hyperexcitability in amyotrophic lateral sclerosis Abstract Amyotrophic lateral sclerosis (ALS) is a type of motor neuron disease (MND) in which humans lose motor functions due to progressive loss of motoneurons in the cortex, brainstem, and spinal cord. In patients and in animal models of MND it has been observed that there is a change in the properties of motoneurons, termed neuronal hyperexcitability, which is an exaggerated response of the neurons to a stimulus. Previous studies suggested neuronal excitability is one of the leading causes for neuronal loss, however the factors that instigate excitability in neurons over the course of disease onset and progression are not well understood, as these studies have looked mainly at embryonic or early postnatal stages (pre-symptomatic).
    [Show full text]
  • MND NSW E-News February 2018
    e-news February 2018 PHOTO Wolf Sverak Photography In this edition NSW researcher awarded prestigious prize… Media announcement of new drug trial in Australia of Tecfidera for MND… Register now for Walk to d’Feet MND Illawarra… International Ask the Experts 6 December webcast recording now available… Wrapping up the 28th International Symposium on ALS/MND, Boston and more A Message from the CEO 2018 is upon us and we’re well into the year already. This action packed e-news features dates and locations for our 2018 Walks to d’Feet on page 4 and a truly comprehensive list of MND NSW Support Services events for 2018 on pages 10 and 11. These events for people living with MND, families and carers are provided at no charge to those attending. This is only possible through the continued support of community fundraisers, such as those listed on page 12. Thank you for your efforts. Thank you also to the staff from the Department of the Environment and Energy in Canberra (pictured above) for their ongoing support through the Scott Lisle Memorial Ice Bucket Challenge held annually in memory of Scott, a former colleague. Staff braved the ice bucket in November 2017 raising $7,000 towards support for people living with MND and MND research. Graham Opie MND NSW provides information, support, education, services for people living with motor neurone disease, their families, friends and carers, health, community and residential care professionals in NSW, ACT, the Gold Coast and NT. 2 e-news February 2018 Newcastle Italian Film Festival Thank you to Nick Moretti from the Newcastle Italian Film Festival for your continued support and donation of $15,000.
    [Show full text]
  • Dynamic Interplay Between H-Current and M-Current Controls Motoneuron
    Buskila et al. Cell Death and Disease (2019) 10:310 https://doi.org/10.1038/s41419-019-1538-9 Cell Death & Disease ARTICLE Open Access Dynamic interplay between H-current and M-current controls motoneuron hyperexcitability in amyotrophic lateral sclerosis Yossi Buskila1,2,OrsolyaKékesi1,2,3,4, Alba Bellot-Saez1,2,WinstonSeah1,2,3,4,TraceyBerg3,4, Michael Trpceski3,4, Justin J. Yerbury3,4 and Lezanne Ooi3,4 Abstract Amyotrophic lateral sclerosis (ALS) is a type of motor neuron disease (MND) in which humans lose motor functions due to progressive loss of motoneurons in the cortex, brainstem, and spinal cord. In patients and in animal models of MND it has been observed that there is a change in the properties of motoneurons, termed neuronal hyperexcitability, which is an exaggerated response of the neurons to a stimulus. Previous studies suggested neuronal excitability is one of the leading causes for neuronal loss, however the factors that instigate excitability in neurons over the course of disease onset and progression are not well understood, as these studies have looked mainly at embryonic or early postnatal stages (pre-symptomatic). As hyperexcitability is not a static phenomenon, the aim of this study was to assess the overall excitability of upper motoneurons during disease progression, specifically focusing on their oscillatory behavior and capabilities to fire repetitively. Our results suggest that increases in the intrinsic excitability of 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; motoneurons are a global phenomenon of aging, however the cellular mechanisms that underlie this hyperexcitability are distinct in SOD1G93A ALS mice compared with wild-type controls. The ionic mechanism driving increased excitability involves alterations of the expression levels of HCN and KCNQ channel genes leading to a complex dynamic of H-current and M-current activation.
    [Show full text]
  • 2018-2019 ANNUAL REPORT Our Vision
    Annual Report 2018 -2019 UOW, ISLHD and the community — Working together for better health Contents Message from the IHMRI Chair ..............................................................................3 Message from the IHMRI Directors ..........................................................................4 IHMRI at a glance 2018-2019 ..............................................................................6 Our research, values and strategic priorities ............................................................8 Research excellence, innovation and translation .....................................................10 People and partners ...........................................................................................12 Stronger community relationships .........................................................................14 Infrastructure and facilities ...................................................................................16 Governance ......................................................................................................18 Income statement and balance sheet .....................................................................20 Funded research 2018 .......................................................................................22 Grant success ....................................................................................................23 Publications .......................................................................................................37 IHMRI acknowledges
    [Show full text]
  • Out of Europe, for Europe: Creating a Global Scientific Network
    WINTER 2010|2011 encounters Newsletter of the European Molecular Biology Organization Out of Europe, for Europe: creating a global scientifi c network by MARIA LEPTIN ◗ From the beginning, all EMBO pro- inhabitants compared to North America’s 343 million) emerges as our grammes and activities were intended to strongest partner. catalyse cross-border exchange of ideas and The numbers clearly illustrate room for improvement in our inter- knowledge. As a European organization actions with the other continents. The large numbers in the green EMBO funds activities to support the molecu- and pale orange circles indicate that in some programmes we have lar life sciences in Europe. But it has always good contacts with South America, Africa and Asia. However, In the been recognized that ‘good for Europe’ does case of the EMBO Short-Term Fellowships, the participating scientists not mean ‘restricted to Europe’. Thus the eli- often come to Europe from countries with a strong need for training in gibility criteria for EMBO Fellowships, which new methods and technologies. The high numbers in the green circles stipulate that the applicant move to another country, allow scientists include many EMBO-funded plenary speakers at meetings. These from the EMBO Member States to take their fellowships abroad, and activities are benefi cial even if they do not represent a sustained coop- young scientists from any country in the world to apply for fellow- eration with the partner countries. They are one way in which EMBO ships to work in one of the member states. The courses, workshops can begin to establish more intensive relations, and they may serve to and meetings we fund accept participants without any national re- open up paths for high-level, broad co-operations.
    [Show full text]
  • Natalie Farrawell
    © 2018. Published by The Company of Biologists Ltd | Journal of Cell Science (2018) 131, jcs220806. doi:10.1242/jcs.220806 FIRST PERSON First person – Natalie Farrawell First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping early-career researchers promote themselves alongside their papers. Natalie Farrawell is the first author on ‘SOD1A4V aggregation alters ubiquitin homeostasis in a cell model of ALS’, published in Journal of Cell Science. Natalie is a Senior Research Assistant in the lab of Justin Yerbury at the Illawarra Health and Medical Research Institute, University of Wollongong, Australia, investigating the molecular processes underpinning amyotrophic lateral sclerosis (ALS), with a particular emphasis on protein misfolding, protein aggregation and inclusion formation. How would you explain the main findings of your paper in lay terms? Inside each of the cells within our body are millions of protein molecules bustling about and working hard. Proteins have many functions; for example, they can be used as building blocks or transporters. Various molecular systems within cells recognise whether or not proteins are functioning normally. When proteins are damaged and cannot function normally, an important cellular garbage disposal system is called upon. Ubiquitin is the molecule responsible for targeting damaged proteins to the cells’ garbage disposal machinery. In amyotrophic lateral sclerosis (ALS, also known as motor neurone disease or Lou Gehrig’s disease), damaged proteins accumulate and form toxic deposits called inclusions that can’t be disposed of by the cell very quickly. In our study, we found that these inclusions contain large amounts of ubiquitin, which means that the levels of free ubiquitin Natalie Farrawell within the cell are compromised and the cellular garbage disposal system is perturbed, eventually leading to cell death.
    [Show full text]
  • Dendritic Computation
    AR245-NE28-18 ARI 13 May 2005 14:15 Dendritic Computation Michael London and Michael Hausser¨ Wolfson Institute for Biomedical Research and Department of Physiology, University College London, London WC1E 6BT; email: [email protected], [email protected] Annu. Rev. Neurosci. Key Words 2005. 28:503–32 dendrites, coding, synaptic integration, spikes, ion channels doi: 10.1146/ annurev.neuro.28.061604.135703 by University of California - San Diego on 09/20/09. For personal use only. Abstract Copyright c 2005 by Annual Reviews. All rights One of the central questions in neuroscience is how particular tasks, Annu. Rev. Neurosci. 2005.28:503-532. Downloaded from arjournals.annualreviews.org reserved or computations, are implemented by neural networks to generate 0147-006X/05/0721- behavior. The prevailing view has been that information processing 0503$20.00 in neural networks results primarily from the properties of synapses and the connectivity of neurons within the network, with the intrinsic excitability of single neurons playing a lesser role. As a consequence, the contribution of single neurons to computation in the brain has long been underestimated. Here we review recent work showing that neuronal dendrites exhibit a range of linear and nonlinear mecha- nisms that allow them to implement elementary computations. We discuss why these dendritic properties may be essential for the com- putations performed by the neuron and the network and provide theoretical and experimental examples to support this view. 503 AR245-NE28-18 ARI 13 May 2005 14:15 ties have been attributed to the individual Contents neuron, with the complex computations that are the hallmark of brains being performed INTRODUCTION................
    [Show full text]
  • Emmanuelle Charpentier Meet the Scientist Interviews Tara
    SUMMER 2015 ISSUE 30 Tara Oceans Expedition unveils scientific results pageS 8 – 9 EMBO Members 2015 Interview Meet the scientist Emmanuelle EMBO Member interviews Charpentier pageS 4 – 5 pageS 13 News EMBO Gold Medallists meet in Feature EMBO Member Mike Jetten has News Instituto Gulbenkian de Ciência Singapore for scientific symposium been searching for anaerobic bacteria to offers germ-free mice for scientific research help improve the environment and health PAGE 2 – 3 PAGE 7 PAGE 10 www.embo.org NEWS © Lee Kong Chian School of Medicine EMBO Gold Medallists meet in Left to right: Christof Niehrs, Erwin Wagner, Richard Singapore Treisman, Jiří Friml, James Briscoe, Sophie Martin, Matthew Freeman, Carl-Henrik Heldin, Dirk Görlich The EMBO Gold Medallist Symposium 2015 took place at the Biopolis in Singapore over three days from 11–13 May. More than 450 scientists and researchers converged on the Matrix Building’s Breakthrough & Discovery Theatrette to hear talks from previous winners of the EMBO Gold Medal. The event was jointly organized by LKCMedicine and decades, including a presentation from the 1990 A*STAR. Gold Medal winner Professor Erwin Wagner from the Spanish National Cancer Research Centre (CNIO). Wagner is currently Director of the newly founded BBVA Foundation – CNIO Cancer KCMedicine Vice-Dean for Research contributions to the life sciences and I am excited Cell Biology Programme as well as Head of the Professor Philip Ingham FRS and Maria to learn about the progress they have made in Genes, Development and Disease Group at the LLeptin, Director of EMBO, welcomed their research,” said Leptin. She also outlined CNIO.
    [Show full text]